Talgesic 0.3mg Injection
Marketer
Indus Pharma Pvt Ltd
Salt Composition
Buprenorphine (0.3mg)
Overview Talgesic 0.3mg Injection
Buprenorphine 0.3mg Injection is indicated for managing moderate to severe pain and managing opioid (morphine) addiction in patients concurrently receiving comprehensive medical, social, and psychological care. This medication is contraindicated in individuals under 16. Administration should always be performed by a qualified healthcare professional; self-administration is strictly prohibited. Dosage and treatment length are determined by the underlying condition and therapeutic response. Treatment should continue as directed by your physician. Frequently reported adverse effects encompass fatigue, opioid withdrawal symptoms, apprehension, restlessness, lightheadedness, cephalalgia, somnolence, bowel looseness, nausea, emesis, and abdominal discomfort. Persistent or worsening side effects necessitate immediate medical attention. Your doctor can provide strategies for mitigation. Prior to commencing therapy, inform your physician of any pre-existing respiratory ailments, cardiac, hepatic, or renal impairments. Complete disclosure of all other medications is crucial due to potential drug interactions. Pregnant or lactating individuals should seek medical counsel before initiating treatment. Long-term use may necessitate routine monitoring of renal and hepatic function, along with blood component levels.
Uses of Talgesic 0.3mg Injection
Morphine addiction; Management of significant to intense pain
Major Benefits of Talgesic 0.3mg Injection:
Administering this medication will be handled by your physician or their designated nurse; please refrain from self-medication.
Common Side effects of Talgesic 0.3mg Injection:
- Headache
- Back pain
- Drowsiness
- Vomiting
- Insomnia (difficulty in sleeping)
- Drug withdrawal syndrome
- Dizziness
- Sleepiness
- Abdominal pain
- Weakness
- Sweating
- Constipation
- Withdrawal syndrome
- Infection
- Vertigo
- Inflammation of the nose
- Chills
- Flu-like symptoms
- Nausea
How to use Talgesic 0.3mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Talgesic 0.3mg Injection works:
Nucynta 0.3mg Injection, a partial opioid agonist, alleviates pain by modulating specific brain receptors, thus altering pain perception and response.
SAFETY ADVICE
AlcoholUNSAFE
Combining Talgesic 0.3mg Injection and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Administering Talgesic 0.3mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible adverse effects prior to prescription. Consult your physician for advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Talgesic 0.3mg Injection while breastfeeding carries a likely risk. Available human data indicates potential transfer to breast milk, posing a possible threat to the infant.
DrivingUNSAFE
Administering a 0.3mg Talgesic injection may induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Administering Talgesic 0.3mg Injection to individuals with significant renal impairment requires careful consideration. Dosage modification for Talgesic 0.3mg Injection may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Talgesic 0.3mg Injection cautiously, potentially requiring dose modification. Physician consultation is advised. Talgesic 0.3mg Injection is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Talgesic 0.3mg Injection :
NA
Facts to Know About Talgesic 0.3mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phenanthrene Derivatives |
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Behavioral Class | Partial Opioid Agonists |
3,018 People bought this recently